| 前收市價 | 1.1600 |
| 開市 | 1.1600 |
| 買盤 | 1.1300 x 200 |
| 賣出價 | 1.1600 x 100 |
| 今日波幅 | 1.1300 - 1.1600 |
| 52 週波幅 | 0.8000 - 2.1000 |
| 成交量 | |
| 平均成交量 | 1,210,132 |
| 市值 | 129.995M |
| Beta 值 (5 年，每月) | -0.10 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.2700 |
| 業績公佈日 | 2024年8月08日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 3.50 |
ZacksOptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
OptiNose (OPTN) delivered earnings and revenue surprises of -20% and 6.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksWill Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
Gain Therapeutics (GANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksWill OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know
OptiNose (OPTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
